236 related articles for article (PubMed ID: 11313370)
1. Papillomavirus-like particles induce acute activation of dendritic cells.
Lenz P; Day PM; Pang YY; Frye SA; Jensen PN; Lowy DR; Schiller JT
J Immunol; 2001 May; 166(9):5346-55. PubMed ID: 11313370
[TBL] [Abstract][Full Text] [Related]
2. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Yang R; Murillo FM; Cui H; Blosser R; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Virol; 2004 Oct; 78(20):11152-60. PubMed ID: 15452235
[TBL] [Abstract][Full Text] [Related]
3. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro.
Rudolf MP; Fausch SC; Da Silva DM; Kast WM
J Immunol; 2001 May; 166(10):5917-24. PubMed ID: 11342606
[TBL] [Abstract][Full Text] [Related]
4. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
5. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
Lenz P; Lowy DR; Schiller JT
Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
Liu XS; Abdul-Jabbar I; Qi YM; Frazer IH; Zhou J
Virology; 1998 Dec; 252(1):39-45. PubMed ID: 9875315
[TBL] [Abstract][Full Text] [Related]
7. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.
Zhao Q; Modis Y; High K; Towne V; Meng Y; Wang Y; Alexandroff J; Brown M; Carragher B; Potter CS; Abraham D; Wohlpart D; Kosinski M; Washabaugh MW; Sitrin RD
Virol J; 2012 Feb; 9():52. PubMed ID: 22356831
[TBL] [Abstract][Full Text] [Related]
8. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
9. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.
Greenstone HL; Nieland JD; de Visser KE; De Bruijn ML; Kirnbauer R; Roden RB; Lowy DR; Kast WM; Schiller JT
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1800-5. PubMed ID: 9465097
[TBL] [Abstract][Full Text] [Related]
10. B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88.
Yang R; Murillo FM; Delannoy MJ; Blosser RL; Yutzy WH; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Immunol; 2005 Jun; 174(12):7912-9. PubMed ID: 15944297
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.
Istrate C; Douagi I; Charpilienne A; McInerney GM; Hidmark A; Johansen K; Larsson M; Magnusson KE; Poncet D; Svensson L; Hinkula J
Scand J Immunol; 2007 Jun; 65(6):494-502. PubMed ID: 17523941
[TBL] [Abstract][Full Text] [Related]
12. Papillomavirus-like particle based vaccines: cervical cancer and beyond.
Schiller JT; Lowy DR
Expert Opin Biol Ther; 2001 Jul; 1(4):571-81. PubMed ID: 11727495
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro.
Warrino DE; Olson WC; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Da Silva DM; Kast WM; Storkus WJ
Hum Immunol; 2005 Jul; 66(7):762-72. PubMed ID: 16112023
[TBL] [Abstract][Full Text] [Related]
14. Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol.
Freyschmidt EJ; Alonso A; Hartmann G; Gissmann L
Antivir Ther; 2004 Aug; 9(4):479-89. PubMed ID: 15456078
[TBL] [Abstract][Full Text] [Related]
15. Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.
Balmelli C; Demotz S; Acha-Orbea H; De Grandi P; Nardelli-Haefliger D
J Virol; 2002 Dec; 76(24):12596-602. PubMed ID: 12438585
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulations.
Yang R; Murillo FM; Lin KY; Yutzy WH; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Immunol; 2004 Aug; 173(4):2624-31. PubMed ID: 15294979
[TBL] [Abstract][Full Text] [Related]
17. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.
Wakabayashi MT; Da Silva DM; Potkul RK; Kast WM
Intervirology; 2002; 45(4-6):300-7. PubMed ID: 12566713
[TBL] [Abstract][Full Text] [Related]
18. Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells.
Lenz P; Thompson CD; Day PM; Bacot SM; Lowy DR; Schiller JT
Clin Immunol; 2003 Mar; 106(3):231-7. PubMed ID: 12706410
[TBL] [Abstract][Full Text] [Related]
19. Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops.
Slupetzky K; Shafti-Keramat S; Lenz P; Brandt S; Grassauer A; Sara M; Kirnbauer R
J Gen Virol; 2001 Nov; 82(Pt 11):2799-2804. PubMed ID: 11602792
[TBL] [Abstract][Full Text] [Related]
20. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
